Mayne Pharma Group Ltd
ASX:MYX
Mayne Pharma Group Ltd
ASX:MYX
Price:
5.74 AUD
-9.89%
Market Closed
Updated:
May 20, 2024
Mayne Pharma Group Ltd
Deferred Income Tax
|
Mayne Pharma Group Ltd
Deferred Income Tax Peer Comparison
Comparables:
RCE
NEU
BOT
PBP
C
CU6
Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Deferred Income Tax
AU$7.8m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Probiotec Ltd
ASX:PBP
|
Deferred Income Tax
AU$17m
|
CAGR 3-Years
7%
|
CAGR 5-Years
19%
|
CAGR 10-Years
9%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mayne Pharma Group Ltd's Deferred Income Tax?
Deferred Income Tax
7.8m
AUD
7.8m
AUD
Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Deferred Income Tax amounts to 7.8m AUD.
What is Mayne Pharma Group Ltd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
-26%
-26%
Over the last year, the Deferred Income Tax growth was 29%. The average annual Deferred Income Tax growth rates for Mayne Pharma Group Ltd have been -35% over the past three years , -26% over the past five years .
You don't have any saved screeners yet
